Akari Therapeutics ADR (AKTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
| Operating Expenses | 2,927 | 7,449 | 5,989 | 5,090 | 2,507 |
| Operating Income | -2,927 | -7,449 | -5,989 | -5,090 | -2,507 |
| Interest Expense | 69 | 51 | 0 | 0 | 0 |
| Other Income | 101 | -58 | 423 | 952 | -364 |
| Pre-tax Income | -2,895 | -7,558 | -5,566 | -4,138 | -2,871 |
| Net Income Continuous | -2,895 | -7,558 | -5,566 | -4,138 | -2,871 |
| Net Income | $-2,895 | $-7,558 | $-5,566 | $-4,138 | $-2,871 |
| EPS Basic Total Ops | -0.24 | -0.80 | -0.83 | -0.95 | -0.57 |
| EPS Basic Continuous Ops | -0.24 | -0.80 | -0.83 | -0.95 | -0.57 |
| EPS Diluted Total Ops | -0.24 | -0.80 | -0.83 | -0.95 | -0.57 |
| EPS Diluted Continuous Ops | -0.24 | -0.80 | -0.83 | -0.95 | -0.57 |
| EBITDA(a) | $-2,927 | $-7,449 | $-5,976 | $-5,089 | $-2,506 |